These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pure red-cell aplasia and recombinant erythropoietin. Gershon SK; Luksenburg H; Coté TR; Braun MM N Engl J Med; 2002 May; 346(20):1584-6; author reply 1584-6. PubMed ID: 12015400 [No Abstract] [Full Text] [Related]
4. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847 [TBL] [Abstract][Full Text] [Related]
5. Pure red cell aplasia induced by erythropoiesis-stimulating agents. Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785 [TBL] [Abstract][Full Text] [Related]
6. Pure red-cell aplasia secondary to antierythropoietin antibodies. Guest SS; Levitt L N Engl J Med; 2003 Dec; 349(26):2572-3. PubMed ID: 14695426 [No Abstract] [Full Text] [Related]
7. Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? Locatelli F; Aljama P; Barany P; Canaud B; Carrera F; Eckardt KU; Macdougall IC; Macleod A; Hörl WH; Wiecek A; Cameron S Nephrol Dial Transplant; 2004 Feb; 19(2):288-93. PubMed ID: 14736947 [No Abstract] [Full Text] [Related]
8. Pure red cell aplasia due to follow-on epoetin. Keithi-Reddy SR; Kandasamy S; Singh AK Kidney Int; 2008 Dec; 74(12):1617-22. PubMed ID: 18547998 [No Abstract] [Full Text] [Related]
9. Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta. Manenti L; Vaglio A Nephrol Dial Transplant; 2007 May; 22(5):1465-7. PubMed ID: 17337465 [No Abstract] [Full Text] [Related]
10. Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia. Summers SA; Matijevic A; Almond MK Nephrol Dial Transplant; 2004 Aug; 19(8):2137-9. PubMed ID: 15252175 [No Abstract] [Full Text] [Related]
11. Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis. Coronel F; García-Mena M; Martínez R Clin Nephrol; 2004 Feb; 61(2):155-8. PubMed ID: 14989637 [TBL] [Abstract][Full Text] [Related]
12. Pure red-cell aplasia: an emerging epidemic in dialysis patients? Anand S; Nissenson AR Perit Dial Int; 2003; 23(4):317-9. PubMed ID: 12968837 [No Abstract] [Full Text] [Related]
13. Pure red cell aplasia secondary to treatment with erythropoietin. Locatelli F; Del Vecchio L J Nephrol; 2003; 16(4):461-6. PubMed ID: 14696747 [TBL] [Abstract][Full Text] [Related]
14. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients]. Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943 [TBL] [Abstract][Full Text] [Related]
15. Epoetin-induced pure red cell aplasia successfully treated with androgens. Sánchez de la Nieta MD; Caparrós G; Rivera F J Nephrol; 2006; 19(2):220-1. PubMed ID: 16736425 [TBL] [Abstract][Full Text] [Related]
16. Recovery of native erythropoietin in a patient with erythropoietin-associated pure red cell aplasia. Prus KM; Al-Rahawan MM Pediatr Nephrol; 2014 Jan; 29(1):161-2. PubMed ID: 23917451 [No Abstract] [Full Text] [Related]
17. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study. Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775 [TBL] [Abstract][Full Text] [Related]
18. Pure red-cell aplasia in a peritoneal dialysis patient with HCV-related cryoglobulinemia in the absence of neutralizing antierythropoietin antibodies. Aterini S; Fusco I; Amato M J Nephrol; 2004; 17(5):744-6. PubMed ID: 15593045 [TBL] [Abstract][Full Text] [Related]
19. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another. Macdougall IC Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076 [TBL] [Abstract][Full Text] [Related]
20. Eprex (recombinant human erythropoietin alfa) and pure red cell aplasia--recommendations for administration to patients with CRF. S Afr Med J; 2003 Nov; 93(11):839. PubMed ID: 14677505 [No Abstract] [Full Text] [Related] [Next] [New Search]